Cargando…
Cardiovascular manifestations secondary to COVID-19: A narrative review
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly, becoming a major threat to global health. In addition to having required the adaptation of healthcare workers for almost 2 years, it has been much talked about, both in the media and among the scientific community. Beyond lung dama...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SPLF and Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065692/ https://www.ncbi.nlm.nih.gov/pubmed/35525097 http://dx.doi.org/10.1016/j.resmer.2022.100904 |
_version_ | 1784699640739790848 |
---|---|
author | Fauvel, C. Trimaille, A. Weizman, O. Pezel, T. Mika, D. Waldmann, V. Cohen, A. Bonnet, G. |
author_facet | Fauvel, C. Trimaille, A. Weizman, O. Pezel, T. Mika, D. Waldmann, V. Cohen, A. Bonnet, G. |
author_sort | Fauvel, C. |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly, becoming a major threat to global health. In addition to having required the adaptation of healthcare workers for almost 2 years, it has been much talked about, both in the media and among the scientific community. Beyond lung damage and respiratory symptoms, the involvement of the cardiovascular system largely explains COVID-19 morbimortality. In this review, we emphasize that cardiovascular involvement is common and is associated with a worse prognosis, and that earlier detection by physicians should lead to better management. First, direct cardiac involvement will be discussed, in the form of COVID-19 myocarditis, then secondary cardiac involvement, such as myocardial injury, myocardial infarction and arrhythmias, will be considered. Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects and cardiovascular complications of COVID-19 vaccines. |
format | Online Article Text |
id | pubmed-9065692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SPLF and Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90656922022-05-04 Cardiovascular manifestations secondary to COVID-19: A narrative review Fauvel, C. Trimaille, A. Weizman, O. Pezel, T. Mika, D. Waldmann, V. Cohen, A. Bonnet, G. Respir Med Res Article The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly, becoming a major threat to global health. In addition to having required the adaptation of healthcare workers for almost 2 years, it has been much talked about, both in the media and among the scientific community. Beyond lung damage and respiratory symptoms, the involvement of the cardiovascular system largely explains COVID-19 morbimortality. In this review, we emphasize that cardiovascular involvement is common and is associated with a worse prognosis, and that earlier detection by physicians should lead to better management. First, direct cardiac involvement will be discussed, in the form of COVID-19 myocarditis, then secondary cardiac involvement, such as myocardial injury, myocardial infarction and arrhythmias, will be considered. Finally, worsening of previous cardiovascular disease as a result of COVID-19 will be examined, as well as long-term COVID-19 effects and cardiovascular complications of COVID-19 vaccines. SPLF and Elsevier Masson SAS. 2022-05 2022-05-04 /pmc/articles/PMC9065692/ /pubmed/35525097 http://dx.doi.org/10.1016/j.resmer.2022.100904 Text en © 2022 SPLF and Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Fauvel, C. Trimaille, A. Weizman, O. Pezel, T. Mika, D. Waldmann, V. Cohen, A. Bonnet, G. Cardiovascular manifestations secondary to COVID-19: A narrative review |
title | Cardiovascular manifestations secondary to COVID-19: A narrative review |
title_full | Cardiovascular manifestations secondary to COVID-19: A narrative review |
title_fullStr | Cardiovascular manifestations secondary to COVID-19: A narrative review |
title_full_unstemmed | Cardiovascular manifestations secondary to COVID-19: A narrative review |
title_short | Cardiovascular manifestations secondary to COVID-19: A narrative review |
title_sort | cardiovascular manifestations secondary to covid-19: a narrative review |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065692/ https://www.ncbi.nlm.nih.gov/pubmed/35525097 http://dx.doi.org/10.1016/j.resmer.2022.100904 |
work_keys_str_mv | AT fauvelc cardiovascularmanifestationssecondarytocovid19anarrativereview AT trimaillea cardiovascularmanifestationssecondarytocovid19anarrativereview AT weizmano cardiovascularmanifestationssecondarytocovid19anarrativereview AT pezelt cardiovascularmanifestationssecondarytocovid19anarrativereview AT mikad cardiovascularmanifestationssecondarytocovid19anarrativereview AT waldmannv cardiovascularmanifestationssecondarytocovid19anarrativereview AT cohena cardiovascularmanifestationssecondarytocovid19anarrativereview AT bonnetg cardiovascularmanifestationssecondarytocovid19anarrativereview |